Western Alliance is committed to building research in western Victoria and supporting the translation of research findings into healthcare. Central to this commitment is the Western Alliance Supporting Translation of Research in Rural and Regional setting (STaRR) Program, which builds health...

A vaccine trialled at Barwon Health has been approved for use on pregnant women in America to protect babies from respiratory syncytial virus (RSV). Pfizer’s Abrysvo vaccine has been approved by the US FDA as the first maternal vaccine to help protect infants at birth through six months from...

PRT-E is a unique research initiative built on partnerships with a diverse community of pregnancy care stakeholders. We’re a collaborative group of pregnancy care clinicians, community members and researchers working together to develop locally relevant and innovative solutions to complex...